Wave Life Sciences (WVE) shares fell nearly 50% to $6.20 after BofA and Wells Fargo cut price targets to $21 and $13 respectively, citing insufficient data for WVE-007 as a standalone obesity ...
Add Yahoo as a preferred source to see more of our stories on Google. Prepare for a splash-filled lineup of pure chaos where every water moment takes a hilarious turn for the worse.
Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets following updated Phase 1 INLIGHT trial data for WVE-007, the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results